Protalix BioTherapeutics Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Aharon Schwartz | 1 | 110,000 |
Dror Bashan | 1 | 64,516 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 0 | 0 |
最近12个月 | 64,516 | 0 | 64,516 |
最近18个月 | 174,516 | 0 | 174,516 |
Protalix BioTherapeutics Inc 内部交易
Protalix BioTherapeutics Inc 最新内部交易
Dror Bashan | PRESIDENT & CEO | 2023-10-19 | 买入 | 64,516 | 132,516 |
$1.4
|
-19.29%
|
Aharon Schwartz | 董事 | 2023-01-03 | 买入 | 110,000 | 174,000 |
$1.42
|
-20.42%
|
Dror Bashan | President & CEO | 2022-04-11 | 买入 | 68,000 | 1,153,458 |
$1.5
|
-24.67%
|
Dexcel Pharma Technologies Ltd. | 10% Owner | 2021-06-03 | 卖出 | 918,717 | 3,637,314 |
$2.27
|
-50.22%
|
Aharon Schwartz | 董事 | 2020-04-07 | 买入 | 64,000 | 64,000 |
$2.43
|
-53.50%
|
Moshe Manor | President & CEO | 2017-05-16 | 买入 | 500 | 50,000 |
$8.1
|
-86.05%
|
Camber Capital Management Lp | 10% Owner | 2016-12-02 | 卖出 | 25,000 | 10,775,000 |
$3.2
|
-64.69%
|
Maimon Yossi | Vice President & CFO | 2015-12-14 | 买入 | 100 | 195,000 |
$7.8
|
-85.51%
|
Camber Capital Management Lp | 10% Owner | 2015-10-19 | 买入 | 40,004 | 26,549,577 |
$10
|
-88.70%
|
Bronfeld Zeev | Director, 10% Owner | 2014-08-13 | 卖出 | 44,000 | 10,066,319 |
$24.7
|
-95.43%
|